Worldwide Regulatory Reliance: Results of an Executed Chemistry, Manufacturing, and Control Post-Approval Change Pilot

References

1. 1.↵
   1. Dellepiane N.,
   2. Pagliusi S.,
   3. Akut P.,
   4. Comellas S.,
   5. De Clercq N.,
   6. Ghadge S.,
   7. Gastineau T.,
   8. McGoldrick M.,
   9. Nurnaeni I.,
   10. Scheppler L.

   Alignment in Post-Approval Changes (PAC) Guidelines in Emerging Countries May Increase Timely Access to Vaccines: An Illustrative Assessment by Manufacturers. Vaccine: X 2020, 6, 100075.

   OpenUrlPubMed
2. 2.↵
   1. Zerhouni E.,
   2. Hamburg M.

   The Need for Global Regulatory Harmonization: A Public Health Imperative. Sci. Transl. Med. 2016, 8 (338), 338ed6.

   OpenUrlFREE Full Text
3. 3.↵
   1. Hoath C.,
   2. Chang L.,
   3. Iyer K. R.,
   4. Kutza J.,
   5. Murray S.,
   6. Smith H.,
   7. Payne R.

   Postapproval Changes for Biopharmaceutical Drug-Substance and Drug-Product Manufacture; Regulatory Complexity and Impact. BioProcess Int. 2016, 14, 38–43.

   OpenUrl
4. 4.↵
   1. O’Brien J.,
   2. Lumsden R. S.,
   3. Diehl D. H.,
   4. Macdonald J. C.

   Building a Better Approach for the Benefit of Patients: 10 Pillars to Strengthen Regulatory Review Systems Globally. Ther. Innovation Regul. Sci. 2020, 54 (2), 283–292.

   OpenUrl
5. 5.↵
   1. Rodriguez H.,
   2. De Lucia M. L.

   A Proposal of a Combined Convergence Regulatory Strategy Applied to Post-Approval Changes by Latin American Countries, Reducing Workload and Allowing Continuous Improvement to Guarantee the Quality, Safety, and Efficacy of Medicines. Front. Med. (Lausanne) 2021, 8, 768376.

   OpenUrlPubMed
6. 6.↵
   1. Gastineau T.

   What Can Vaccines Learn from Aviation? Vaccine 2020, 38 (33), 5082–5084.

   OpenUrlPubMed
7. 7.↵
   World Health Organization. WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce: With an Updated List of Participating Countries, Rev. 5. World Health Organization, 1997. https://apps.who.int/iris/handle/10665/63547 (accessed February 15, 2024).
8. 8.↵
   The Complex Journey of a Vaccine – Part II: Immunization Supply Chain, Delivery Innovation, and Regulatory Requirements; IFPMA, 2016. https://ifpma.org/wp-content/uploads/2023/01/i2023_IFPMA-ComplexJourney-Part_Two_2016.pdf (accessed May 6, 2024).
9. 9.↵
   1. Gastineau T.,
   2. Ban C.,
   3. Basso A.,
   4. Brehme F.,
   5. Silva A. L.,
   6. Faure O.,
   7. Le Palaire L.,
   8. Persaud P.,
   9. Rodriguez H.

   Worldwide Regulatory Reliance: Launching A Pilot on A Chemistry, Manufacturing and Control Post Approval Change for A Vaccine. PDA J. Pharm. Sci. Technol. 2024, 78 (4), 388–398.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    World Health Organization. WHO-Listed Authority (WLA). https://www.who.int/initiatives/who-listed-authority-reg-authorities (accessed July 19, 2024).
11. 11.↵
    WHO Expert Committee on Specifications for Pharmaceutical Preparations. Annex 10: Good Reliance Practices in the Regulation of Medical Products: High Level Principles and Considerations; WHO Technical Report Series No.1033; WHO, 2021.
12. 12.↵
    WHO Expert Committee on Biological Standardization. Annex 4: Guidelines on Procedures and Data Requirements for Changes to Approved Vaccines; WHO Technical Report Series No.993; WHO, 2015.